As indicated by MTT analysis and previous in vivo studies with an immune-deficient nude mouse model [17], nNOS inhibitors exhibit direct cytotoxicity to melanoma cells independent of PD-1- and PD-L1-mediated immune suppression. The gene discussed is NOS1; the disease is melanoma.